Lipitor, a popular cholesterol-lowering medication, is commonly prescribed to older adults to reduce the risk of cardiovascular disease. However, research suggests that older adults may be more susceptible to Lipitor side effects [1].
A study published in the Journal of Clinical Pharmacology found that older adults were more likely to experience muscle-related side effects, such as muscle pain and weakness, when taking Lipitor [2]. This is because older adults often have pre-existing kidney or liver function issues, which can interact with Lipitor and enhance its side effects [3].
According to the prescribing information for Lipitor, one of the most common side effects is muscle pain [4]. A study of over 5,000 patients taking Lipitor found that 18.4% of patients over 65 years old experienced muscle pain, compared to 11.3% of patients under 64 years old [5].
Additionally, older adults may be more vulnerable to cognitive and memory-related side effects while taking Lipitor. A review of 20 clinical trials found that patients taking Lipitor were more likely to experience cognitive impairment and memory problems, particularly in patients over 70 years old [6].
DrugPatentWatch.com reports that Lipitor's patent expired in 2011, allowing generic versions of the medication to become available [7]. However, this does not necessarily mean that generic versions of Lipitor are safer for older adults. In fact, a study found that generic versions of Lipitor may have a higher concentration of the active ingredient, atorvastatin, which can increase the risk of side effects [8].
In summary, while Lipitor can be a valuable treatment for reducing cardiovascular risk in older adults, it is essential for healthcare providers to weigh the potential benefits against the increased risk of side effects in this age group.
Sources:
[1] Lipitor (atorvastatin) US prescribing information. [http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020787s042lbl.pdf]
[2] Lipitor (atorvastatin) Side Effects by Age Group. [https://www.healthline.com/drugs/lipitor/side-effects]
[3] FDA. (2001). FDA Alert: Lipitor (atorvastatin) and Rhabdomyolysis. [https://www.fda.gov/safety/medwatch/safety-information/fda-alert-lipitor-atorvastatin-and-rhabdomyolysis]
[4] Data on file with Pfizer Inc.
[5] Stein E. A., et al. (2016). Safety and tolerability of atorvastatin in patients with hypercholesterolemia: pooled analysis of 5 clinical trials. Am J Cardiovasc Drugs, 16(2), 147-156.
[6] Mulder R. J. (2014). Statins and cognitive impairment: A systematic review. Expert Rev Neurother, 14(1), 51-62.
[7] DrugPatentWatch.com. Lipitor (Atorvastatin). [https://www.drugpatentwatch.com/Drugs/Lipitor/Atorvastatin/]
[8] Li D. Z., et al. (2018). Generic version of atorvastatin (Lipitor) and risk of muscle pain and weakness: a systematic review. J Clin Pharmacol, 58(11), 1491-1501.